These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17990314)

  • 1. Oxystress inducing antitumor therapeutics via tumor-targeted delivery of PEG-conjugated D-amino acid oxidase.
    Fang J; Deng D; Nakamura H; Akuta T; Qin H; Iyer AK; Greish K; Maeda H
    Int J Cancer; 2008 Mar; 122(5):1135-44. PubMed ID: 17990314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide.
    Fang J; Sawa T; Akaike T; Maeda H
    Cancer Res; 2002 Jun; 62(11):3138-43. PubMed ID: 12036926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Enzymatically Highly Active Pegylated-D-Amino Acid Oxidase and Its Application to Antitumor Therapy.
    Nakamura H; Enoch A; Iwaya S; Furusho S; Tsunoda S; Haratake M
    Curr Drug Deliv; 2021; 18(8):1121-1129. PubMed ID: 33550973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeted induction of oxystress for cancer therapy.
    Fang J; Nakamura H; Iyer AK
    J Drug Target; 2007; 15(7-8):475-86. PubMed ID: 17671894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin.
    Fang J; Sawa T; Akaike T; Greish K; Maeda H
    Int J Cancer; 2004 Mar; 109(1):1-8. PubMed ID: 14735461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
    Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
    Fang J; Seki T; Maeda H
    Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated D-amino acid oxidase restores bactericidal activity of neutrophils in chronic granulomatous disease via hypochlorite.
    Nakamura H; Fang J; Mizukami T; Nunoi H; Maeda H
    Exp Biol Med (Maywood); 2012 Jun; 237(6):703-8. PubMed ID: 22715431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application.
    Abu Lila AS; Eldin NE; Ichihara M; Ishida T; Kiwada H
    Int J Pharm; 2012 Nov; 438(1-2):176-83. PubMed ID: 22944302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting.
    Kim TH; Jo YG; Jiang HH; Lim SM; Youn YS; Lee S; Chen X; Byun Y; Lee KC
    J Control Release; 2012 Sep; 162(2):422-8. PubMed ID: 22824780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor.
    Fang J; Sawa T; Akaike T; Akuta T; Sahoo SK; Khaled G; Hamada A; Maeda H
    Cancer Res; 2003 Jul; 63(13):3567-74. PubMed ID: 12839943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
    J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of folate-targeted and PEGylated phytosomes loaded with a mitomycin C-soybean phosphatidyhlcholine complex.
    Li Y; Wu H; Jia M; Cui F; Lin J; Yang X; Wang Y; Dai L; Hou Z
    Mol Pharm; 2014 Sep; 11(9):3017-26. PubMed ID: 25054963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A surface charge-switchable and folate modified system for co-delivery of proapoptosis peptide and p53 plasmid in cancer therapy.
    Chen S; Rong L; Lei Q; Cao PX; Qin SY; Zheng DW; Jia HZ; Zhu JY; Cheng SX; Zhuo RX; Zhang XZ
    Biomaterials; 2016 Jan; 77():149-63. PubMed ID: 26599622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization.
    Gong C; Wei X; Wang X; Wang Y; Guo G; Mao Y; Luo F; Qian Z
    Nanotechnology; 2010 May; 21(21):215103. PubMed ID: 20431208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity.
    Cabral H; Nishiyama N; Kataoka K
    J Control Release; 2007 Aug; 121(3):146-55. PubMed ID: 17628162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
    Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
    J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
    Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.
    Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W
    J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
    Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
    Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.